🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Bafna Pharmaceuticals Limited BAFNAPH NSEPHARMA

Healthcare · Drug Manufacturers - Specialty & Generic · India
https://www.bafnapharma.com

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.

READ MORE ›
₹174.15
-10.22% 1Y

Market & Price

Market Cap
₹411.98 Cr
Current Price
₹174.15
High / Low (52W)
₹193.97 / ₹165.86
Beta
0.16

Valuation

Stock P/E
35.32
Industry PE
35.51
Forward P/E
-
PEG Ratio
-
Book Value
₹40.57
Price to Book
4.29
P/S
2.74
EV/EBITDA
28.10
Dividend Yield
-

Profitability & Returns

ROCE
12.36%
ROE
12.27%
ROA
3.76%
Profit Margin
7.37%
Op Margin
4.47%
EPS (Latest Qtr)
₹1.16
EPS (TTM)
₹4.93

Balance Sheet & Liquidity

Debt/Equity
0.39
Quick Ratio
0.80
Current Ratio
1.57
Debt
₹37.43 Cr
Total Assets
₹175.53 Cr
Current Assets
₹89.65 Cr
Working Capital
₹32.46 Cr

Ownership

Promoter Holding
90.22%
Chg in Prom Hold
-
FII / Inst Holding
0.00%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
₹448.13 Cr
Total Revenue (TTM)
₹150.62 Cr
EBITDA
₹15.95 Cr
Free Cash Flow
₹-19.97 Cr
Operating Cash Flow
₹15.37 Cr
Shares Outstanding
₹2.37 Cr
Gross Margin
31.96%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
9.30%
Profit 5Y
-0.71%
Revenue (YoY)
8.10%
Earnings (YoY)
111.00%

PROS

No notable strengths flagged.

CONS

  • Earnings shrank at -0.7% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 BAFNAPH Bafna Pharmaceuticals Limited NSEPHARMA 174.15 35.32 ₹411.98 Cr - 12.36% 12.27% 9.30% -0.71%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,794.20 37.47 ₹4.30 L Cr 0.92% 17.94% 14.72% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 6,655.50 68.67 ₹1.77 L Cr 0.45% 18.96% 16.19% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,572.20 71.63 ₹1.55 L Cr 0.85% 9.05% 16.99% 13.27% 20.22%
5 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 8,493.00 62.93 ₹1.22 L Cr 0.24% 19.79% 21.50% 15.33% 33.34%
6 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,383.30 28.78 ₹1.12 L Cr 0.94% 14.86% 11.74% 7.23% 11.45%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,105.90 22.08 ₹1.11 L Cr 0.09% 19.24% 18.32% 16.55% 36.99%
8 DRREDDY Dr. Reddy's Laboratories Limited NIFTY50NSEAIPHARMA 1,276.00 24.83 ₹1.06 L Cr 0.63% 14.22% 11.83% 10.96% -1.67%
9 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,273.30 19.53 ₹1.04 L Cr 0.53% 28.42% 26.91% 19.10% 131.46%
⚙Ad space

Quarterly Results

Figures in INR.

Metric Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue -39.06 Cr34.62 Cr35.47 Cr38.29 Cr42.24 Cr
Cost of Revenue -26.58 Cr22.42 Cr23.06 Cr27.27 Cr29.74 Cr
Gross Profit -12.48 Cr12.21 Cr12.41 Cr11.02 Cr12.50 Cr
Operating Expenses -9.58 Cr8.51 Cr9.60 Cr9.54 Cr10.62 Cr
Operating Income -2.90 Cr3.70 Cr2.81 Cr1.48 Cr1.89 Cr
EBITDA -2.35 Cr5.66 Cr5.46 Cr4.27 Cr5.31 Cr
Interest Expense -82.22 L90.54 L86.43 L86.24 L1.03 Cr
Pretax Income -1.31 Cr3.39 Cr3.12 Cr1.84 Cr2.62 Cr
Tax Provision -0000-12.96 L
Net Income -1.31 Cr3.39 Cr3.12 Cr1.84 Cr2.75 Cr
Diluted EPS -0.551.431.320.781.16

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue -115.35 Cr152.47 Cr145.86 Cr150.62 Cr
Cost of Revenue -76.59 Cr106.91 Cr103.06 Cr102.48 Cr
Gross Profit -38.76 Cr45.56 Cr42.80 Cr48.13 Cr
Operating Expenses -26.69 Cr39.03 Cr36.51 Cr38.26 Cr
Operating Income -12.07 Cr6.53 Cr6.29 Cr9.88 Cr
EBITDA -18.75 Cr14.28 Cr11.77 Cr20.70 Cr
Interest Expense -1.80 Cr1.94 Cr2.73 Cr3.66 Cr
Pretax Income -11.62 Cr7.35 Cr4.15 Cr10.97 Cr
Tax Provision -27.83 L00-12.96 L
Net Income -11.34 Cr7.35 Cr4.15 Cr11.10 Cr
Diluted EPS -4.793.111.764.69

Compounded Sales Growth

5 Years:9.30%
1 Year:8.10%

Compounded Profit Growth

5 Years:-0.71%
1 Year:111.00%

Stock Price Performance

1 Year:-10.22%
6 Months:-
3 Months:-
1 Month:-

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -129.58 Cr147.68 Cr153.08 Cr175.53 Cr
Current Assets -87.31 Cr93.77 Cr84.73 Cr89.65 Cr
Cash & Equivalents -7.81 Cr1.40 Cr3.43 Cr2.02 Cr
Inventory -22.22 Cr29.64 Cr28.09 Cr28.90 Cr
Receivables -41.15 Cr45.39 Cr40.17 Cr43.93 Cr
Total Liabilities -56.13 Cr66.84 Cr68.27 Cr79.38 Cr
Current Liabilities -46.48 Cr54.08 Cr51.85 Cr57.19 Cr
Long Term Debt -8.43 Cr10.75 Cr14.03 Cr17.78 Cr
Total Debt -22.92 Cr24.39 Cr28.20 Cr37.43 Cr
Total Equity -73.45 Cr80.84 Cr84.81 Cr96.15 Cr
Shares Outstanding -2.37 Cr2.37 Cr2.37 Cr2.37 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -4.95 Cr9.48 Cr22.14 Cr15.37 Cr
Investing Cash Flow --7.49 Cr-15.05 Cr-21.16 Cr-22.40 Cr
Financing Cash Flow -10.18 Cr-84.54 L1.06 Cr5.62 Cr
Capital Expenditure --8.22 Cr-15.85 Cr-21.86 Cr-24.90 Cr
Free Cash Flow --3.27 Cr-6.36 Cr27.62 L-9.53 Cr
Net Change in Cash -7.64 Cr-6.41 Cr2.04 Cr-1.41 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -33.6%29.9%29.3%32.0%
Operating Margin % -10.5%4.3%4.3%6.6%
Net Margin % -9.8%4.8%2.8%7.4%
ROE % -15.4%9.1%4.9%11.5%
ROCE % -14.5%7.0%6.2%8.3%

Shareholding Pattern

Insiders
90.22%
Institutions
0.00%
Public Float
0.00%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for BAFNAPH

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space